Ignite Creation Date:
2024-05-06 @ 1:33 PM
Last Modification Date:
2024-10-26 @ 1:16 PM
Study NCT ID:
NCT04053881
Status:
COMPLETED
Last Update Posted:
2023-01-23
First Post:
2019-08-09
Brief Title:
A Study to Assess How Well Certolizumab Pegol Works in Patients With Moderate to Severe Plaque Psoriasis as Part of Routine Clinical Practice
Sponsor:
UCB Biopharma SRL
Organization:
UCB Pharma
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-08-21
Start Date Type:
ACTUAL
Primary Completion Date:
2022-12-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-12-02
Completion Date Type:
ACTUAL
First Submit Date:
2019-08-09
First Submit QC Date:
August 12 2019
Study First Post Date:
2019-08-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-01-20
Last Update Post Date:
2023-01-23
Last Update Post Date Type:
ACTUAL